论文部分内容阅读
36种药品纳入医保支付范围近日,人社部印发通知,明确将36种药品纳入国家基本医疗保险、工伤保险和生育保险药品目录乙类范围,并确定了医保支付标准。纳入药品目录的36种药品中,有西药31种、中成药5种,涉及肿瘤、糖尿病、心脑血管等多种疾病治疗。如抗肿瘤药中的曲妥珠单抗医保支付标准为7600元(440mg(20ml)/瓶)、糖尿病用药利拉鲁肽为410元(3ml:18mg/支,预填充注射笔),治疗心脑血管的银杏二萜内酯葡胺注射液医保支
36 kinds of drugs included in the scope of medical insurance Recently, the Ministry of Human Resources and Social Security issued a notice, clearly 36 kinds of drugs into the national basic medical insurance, industrial injury insurance and maternity insurance Category B drugs, and set the standard payment of health insurance. Of the 36 drugs included in the drug list, there are 31 western medicines and 5 proprietary Chinese medicines, which are involved in the treatment of various diseases such as cancer, diabetes, cardiovascular and cerebrovascular diseases. Such as antitumor drugs trastuzumab medical insurance payment standard 7600 yuan (440mg (20ml) / bottle), Diabetes drug liraglutide 410 yuan (3ml: 18mg / support, pre-filled injection pen), the treatment of heart Cerebrovascular ginkgo diterpene lactone meglumine injection health care branch